Works matching IS 17762596 AND DT 2021 AND VI 16 AND IP 4

Results: 11

Prognostic Impact of Early Treatment Interruption of Nivolumab Plus Ipilimumab Due to Immune-Related Adverse Events as First-Line Therapy for Metastatic Renal Cell Carcinoma: A Multi-Institution Retrospective Study.

Published in:

2021

By:

Ishihara, Hiroki;
Nemoto, Yuki;
Nakamura, Kazutaka;
Ikeda, Takashi;
Tachibana, Hidekazu;
Fukuda, Hironori;
Yoshida, Kazuhiko;
Kobayashi, Hirohito;
Iizuka, Junpei;
Shimmura, Hiroaki;
Hashimoto, Yasunobu;
Takagi, Toshio;
Ishida, Hideki;
Kondo, Tsunenori;
Tanabe, Kazunari

Publication type:

journal article

Risk and Benefit for Targeted Therapy Agents in Pediatric Phase II Trials in Oncology: A Systematic Review with a Meta-Analysis.

Published in:

Targeted Oncology, 2021, v. 16, n. 4, p. 415, doi. 10.1007/s11523-021-00822-5

By:

Strzebonska, Karolina;
Wasylewski, Mateusz T.;
Zaborowska, Lucja;
Polak, Maciej;
Slugocka, Emilia;
Stras, Jakub;
Blukacz, Mateusz;
Gyawali, Bishal;
Waligora, Marcin

Publication type:

Article

Baseline and Changes in Serum B-Cell Maturation Antigen Levels Rapidly Indicate Changes in Clinical Status Among Patients with Relapsed/Refractory Multiple Myeloma Starting New Therapy.

Published in:

Targeted Oncology, 2021, v. 16, n. 4, p. 503, doi. 10.1007/s11523-021-00821-6

By:

Bujarski, Sean;
Udd, Kyle;
Soof, Camilia;
Chen, Haiming;
Spektor, Tanya M.;
Safaie, Tahmineh;
Li, Mingjie;
Stern, Joshua;
Wang, Cathy;
Xu, Ning;
Emamy-Sadr, Marsiye;
Swift, Regina;
Rahbari, Ashkon;
Patil, Saurabh;
Souther, Eric;
Regidor, Bernard;
Sutanto, Christine;
Berenson, James R.

Publication type:

Article

Starting Imatinib at 400 mg Daily in Patients with Gastrointestinal Stromal Tumors Harboring KIT Exon 9 Mutations: A Retrospective, Multicenter Study.

Published in:

2021

By:

Callejo, Almudena;
Faouzi, Sara;
Bouché, Olivier;
Bertucci, François;
Chevalier, Thomas;
Isambert, Nicolas;
Duffaud, Florence;
Collard, Olivier;
Penel, Nicolas;
Terrier, Philippe;
Mir, Olivier;
Blay, Jean Yves;
Le Cesne, Axel

Publication type:

journal article

The Pan-Immune-Inflammation Value in Patients with Metastatic Melanoma Receiving First-Line Therapy.

Published in:

Targeted Oncology, 2021, v. 16, n. 4, p. 529, doi. 10.1007/s11523-021-00819-0

By:

Fucà, Giovanni;
Beninato, Teresa;
Bini, Marta;
Mazzeo, Laura;
Di Guardo, Lorenza;
Cimminiello, Carolina;
Randon, Giovanni;
Apollonio, Giulia;
Bisogno, Ilaria;
Del Vecchio, Marta;
Lauria Pantano, Claudia;
Di Nicola, Massimo;
de Braud, Filippo;
Del Vecchio, Michele

Publication type:

Article

Safety and Efficacy of Neoadjuvant Immune Checkpoint Inhibitor Therapy in Patients with Resectable Non-small-Cell Lung Cancer: A Systematic Review.

Published in:

Targeted Oncology, 2021, v. 16, n. 4, p. 425, doi. 10.1007/s11523-021-00818-1

By:

Zhao, Ziran;
Gao, Yibo;
Xue, Qi;
Gao, Shugeng;
He, Jie

Publication type:

Article

The Role of p53 Expression in Patients with RAS/BRAF Wild-Type Metastatic Colorectal Cancer Receiving Irinotecan and Cetuximab as Later Line Treatment.

Published in:

Targeted Oncology, 2021, v. 16, n. 4, p. 517, doi. 10.1007/s11523-021-00816-3

By:

Ziranu, Pina;
Lai, Eleonora;
Schirripa, Marta;
Puzzoni, Marco;
Persano, Mara;
Pretta, Andrea;
Munari, Giada;
Liscia, Nicole;
Pusceddu, Valeria;
Loupakis, Fotios;
Demurtas, Laura;
Libertini, Michela;
Mariani, Stefano;
Migliari, Marco;
Dubois, Marco;
Giampieri, Riccardo;
Sotgiu, Giovanni;
Dei Tos, Angelo Paolo;
Lonardi, Sara;
Zaniboni, Alberto

Publication type:

Article

Cardiovascular Toxicities of Antiangiogenic Tyrosine Kinase Inhibitors: A Retrospective, Pharmacovigilance Study.

Published in:

Targeted Oncology, 2021, v. 16, n. 4, p. 471, doi. 10.1007/s11523-021-00817-2

By:

Goldman, Adam;
Bomze, David;
Dankner, Rachel;
Fourey, Dana;
Boursi, Ben;
Arad, Michael;
Maor, Elad

Publication type:

Article

Multicenter, Open-Label, Phase I Study of DSP-7888 Dosing Emulsion in Patients with Advanced Malignancies.

Published in:

Targeted Oncology, 2021, v. 16, n. 4, p. 461, doi. 10.1007/s11523-021-00813-6

By:

Spira, Alexander;
Hansen, Aaron R.;
Harb, Wael A.;
Curtis, Kelly K.;
Koga-Yamakawa, Erina;
Origuchi, Makoto;
Li, Zhonggai;
Ertik, Bella;
Shaib, Walid L.

Publication type:

Article

Bintrafusp Alfa, a Bifunctional Fusion Protein Targeting TGFβ and PD-L1, in Patients with Esophageal Squamous Cell Carcinoma: Results from a Phase 1 Cohort in Asia.

Published in:

Targeted Oncology, 2021, v. 16, n. 4, p. 447, doi. 10.1007/s11523-021-00810-9

By:

Lin, Chia-Chi;
Doi, Toshihiko;
Muro, Kei;
Hou, Ming-Mo;
Esaki, Taito;
Hara, Hiroki;
Chung, Hyun Cheol;
Helwig, Christoph;
Dussault, Isabelle;
Osada, Motonobu;
Kondo, Shunsuke

Publication type:

Article

Bintrafusp Alfa, a Bifunctional Fusion Protein Targeting TGF-β and PD-L1, in Patients with Esophageal Adenocarcinoma: Results from a Phase 1 Cohort.

Published in:

Targeted Oncology, 2021, v. 16, n. 4, p. 435, doi. 10.1007/s11523-021-00809-2

By:

Tan, Benjamin;
Khattak, Adnan;
Felip, Enriqueta;
Kelly, Karen;
Rich, Patricia;
Wang, Ding;
Helwig, Christoph;
Dussault, Isabelle;
Ojalvo, Laureen S.;
Isambert, Nicolas

Publication type:

Article